<code id='FF6425F3B7'></code><style id='FF6425F3B7'></style>
    • <acronym id='FF6425F3B7'></acronym>
      <center id='FF6425F3B7'><center id='FF6425F3B7'><tfoot id='FF6425F3B7'></tfoot></center><abbr id='FF6425F3B7'><dir id='FF6425F3B7'><tfoot id='FF6425F3B7'></tfoot><noframes id='FF6425F3B7'>

    • <optgroup id='FF6425F3B7'><strike id='FF6425F3B7'><sup id='FF6425F3B7'></sup></strike><code id='FF6425F3B7'></code></optgroup>
        1. <b id='FF6425F3B7'><label id='FF6425F3B7'><select id='FF6425F3B7'><dt id='FF6425F3B7'><span id='FF6425F3B7'></span></dt></select></label></b><u id='FF6425F3B7'></u>
          <i id='FF6425F3B7'><strike id='FF6425F3B7'><tt id='FF6425F3B7'><pre id='FF6425F3B7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:1565
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          First Opinion Podcast: How to protect health care in times of war
          First Opinion Podcast: How to protect health care in times of war

          Injusttwoweeks,thebrutalityoftheIsrael-Hamasconflicthasshockedtheworld.Butoneofitsmostheartbreakinga

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Readout Newsletter: What happened with Sarepta's Duchenne data

          AndrewHarnik/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnews